458 related articles for article (PubMed ID: 17571588)
1. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588
[TBL] [Abstract][Full Text] [Related]
2. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Blin N; Morineau N; Gaillard F; Morin O; Milpied N; Harousseau JL; Moreau P
Leuk Lymphoma; 2004 Oct; 45(10):2161-3. PubMed ID: 15370266
[TBL] [Abstract][Full Text] [Related]
3. Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.
Jacobs P; Wood L; Du Toit A; Esterhuizen K
Hematology; 2003 Apr; 8(2):119-23. PubMed ID: 12745662
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
5. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
6. A case of pulmonary aspergillosis with lack of response to caspofungin.
Rüchel R; Perske C; Glass B; Bäsecke J
Rev Iberoam Micol; 2006 Jun; 23(2):94-6. PubMed ID: 16854185
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Verma A; Williams S; Trifilio S; Zembower T; Mehta J
Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
[No Abstract] [Full Text] [Related]
9. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.
Ota H; Yamamoto H; Kimura M; Araoka H; Fujii T; Umeyama T; Ohno H; Miyazaki Y; Kaji D; Taya Y; Nishida A; Ishiwata K; Tsuji M; Takagi S; Asano-Mori Y; Yamamoto G; Uchida N; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
Mycopathologia; 2017 Oct; 182(9-10):847-853. PubMed ID: 28577122
[TBL] [Abstract][Full Text] [Related]
11. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
13. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
Tokimatsu I; Kushima H; Iwata A; Hashinaga K; Umeki K; Ohama M; Kohno K; Ishii H; Kishi K; Ogata M; Hiramatsu K; Saikawa T; Kadota J
Intern Med; 2007; 46(11):775-9. PubMed ID: 17541234
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary mucormycosis in a patient with kidney transplant and uncontrolled haemoptysis].
Navarro Vergara DI; Barragán Pola G; Bonifaz A; Núñez Pérez-Redondo C; Choreño García O; Cicero Sabido R
Rev Iberoam Micol; 2017; 34(4):233-236. PubMed ID: 28757006
[TBL] [Abstract][Full Text] [Related]
15. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
Salonen JH
Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
[No Abstract] [Full Text] [Related]
17. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Bethge WA; Schmalzing M; Stuhler G; Schumacher U; Kröber SM; Horger M; Einsele H; Kanz L; Hebart H
Haematologica; 2005 Nov; 90 Suppl():ECR22. PubMed ID: 16266913
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous mucormycosis.
Vulsteke JB; Deeren D
Transpl Infect Dis; 2019 Apr; 21(2):e13039. PubMed ID: 30548761
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]